John is a 25+ year veteran of the medical device industry with extensive experience in the commercialization of innovative medical technologies. He has successfully managed and built functions ranging from domestic and international sales force management, clinical, regulatory, global marketing, new market development, manufacturing and joint venture agreements. He joined GKC in 2017 as President, CEO and Board Director with a proven track record to spearhead the company’s accelerated growth strategy to meet the demand for its lead product, the Personal KinetiGraph™ (PKG™) system (Parkinson’s KinetiGraph™ system outside of the U.S.).

Before becoming President and CEO of GKC, he served as President and CEO of Monteris Medical Corporation where he oversaw development to commercialization of their MRI guided robotically controlled laser surgical system. Under his leadership, 30 new products were launched with 8 major software releases. Additionally, he raised $61M in equity financing and doubled sales annually between 2012-2015.

Previous to Monteris, John served as the Chief Commercialization Officer for BÂRRX Medical where he led major expansion of US and International selling & marketing organizations; achieving greater than $40M annual revenue before its acquisition by Covidien for $430M. As President and CEO of Softscope Medical Technologies Inc., he led this clinical stage VC backed company in the GI space that was later acquired by Fujifilm Japan.

Earlier in his industry career, John held positions as Vice President of Sales and Marketing for the Peripheral Vascular Division of ev3 Inc., Vice President and General Manager International for ACMI Corporation, and various management positions within Boston Scientific. Prior to his commercial career, he served 7 years as a U.S. Marine Corps pilot.

Frank has over 25 years of medical device leadership and experience in Aesthetics, Dermatology, Gastroenterology, General Surgery, Gynecology & Urology. He has a record of successfully growing companies by working closely with physicians, analyzing the market need, innovating new products & then working with internal teams on execution excellence, sales & profitability.

Just prior to Zerigo, he was CEO & President of Epica International, a developer, manufacturer and seller of advanced CT and Robotic systems. At Epica, in 4 years, he transform the company’s focus & products to include their first 510(k) human medical CT, grew sales from $13M to $27M and generated positive EBITDA.

Prior to Epica, Frank as CEO & President of the plastic surgery/dermatology RF & laser company, Ellman International, grew sales from $19M to $29M. He thereafter sold Ellman to market leader Cynosure.

Frank also co-led the sale of ACMI Corp. to Gyrus Group PLC for $500M, 18x EBITDA and played a lead role in 5 other M&A deals, throughout his career, on both the sell and buy side.

Frank has launched over 250+ new products & break-through technologies (CMOS video, LED illumination endoscopy and RF sealing / cutting); directed production at 5 facilities worldwide and led clinical groups including surgical procedure development, clinical studies & reimbursement.

Frank started his medical device career at American Hospital Supply Corporation and prior thereof his technology career at United Technologies Advance Engineering group. Frank has over 40 issued or pending USA and foreign patents.

Ms. Kotcher brings to Zerigo Health over 25 years of healthcare experience in the medical device field with a focus on managed care contracting, provider relations, reimbursement, healthcare policy, and health economics. Most recently, she served as Senior Director, U.S. Market Access and Reimbursement for Hearflow, and previously worked in market access leadership roles at iRhythm, CardioDx, Pathworks Diagnostics, and Dexcom.